The failure of blood cell production results in the once-dreaded and fatal disease, pernicious anemia
Nadjarzadeh A, Shidfar F, Amirjannati N, et al
In the Phase IIb trial data summarized by Metabolic Pharmaceuticals, participants receiving up to 1 mg/day of oral AOD-9604 for 24 weeks showed no statistically significant changes in fasting glucose, insulin, or IGF-1 compared to placebo [6]
Dosage, delivery method (oral, subcutaneous, or transdermal), and treatment duration should be tailored to each individuals needs and health history
Osteologie 4, 207233
Most peptides reconstituted in bacteriostatic water remain stable for 3-4 weeks at this temperature